Administering a combination of a glutaminase inhibitor and 5FU/DDP to mice with TIGAR-overexpressing ESCC cell grafts and patient-derived tumor grafts led to significant suppression of tumor growth compared to using chemotherapy alone. This evidence concerns the gene GLS and esophageal squamous cell carcinoma.